The Company also announced that the lead investigator for the constipation-predominant irritable bowel syndrome program, Mark Pimentel, MD, has joined Synthetic Biologics as chairman of the clinical advisory board.
Dr. Pimentel is director of the Gastrointestinal Motility Program and Laboratory at Cedars-Sinai Medical Center in Los Angeles.
Synthetic Biologics is a developer of anti-infective biologic and drug candidates targeting specific pathogens.
More Articles on Gastroenterology:
9 Statistics on Gastroenterologist Compensation by Location
AGA Calls for More Transparency From CMS
The Growing Role of Biologics in Gastroenterology
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
